Ukrainian Pharma: challenges and opportunities Pharmaceutical Industry Review, special issue, December 2022
Mariana Martynchuk, General director of FITOFARM: "We Work, We Help Front, We Support Ukraine"
For PJSC FITOFARM the far started much earlier that February 24, 2022. Our company is at the front line since 2015 when we were just 20 km far away. We worked all the time even when the company was on temporary occupied territory/ Nowadays together with all the country for over 10 months we go along the hard way to the Victory. It makes no sense to list all the difficulties we were facing with. The major point is that we look for and find the ways and solutions.
W 54
INFORMATION ON THE COMPANY
e defined the priorities and structured our activities pursuant to new
business tasks. The first component is safety of our employees. For manufacturing facilities in the city of Bakhmut it immediately became a very urgent issue. During the short time we evacuated our employees
BACK TO CONTENTS
to more safe regions of Ukraine. Majority of them moved to Kyiv where company’s head office is located. Practically all vacancies which the company opened since the war started were filled with internal candidates. We also support army divisions where our mobilized colleagues are enrolled – supply
PJSC FITOFARM is a national pharmaceutical company from the city of Bakhmut. FITOFARM has been operating on the Ukrainian market for more than 48 years. Before the full-scale invasion, the company's portfolio included more than 80 names of medicinal products of both herbal and synthetic origin. The company's drugs are used in surgery, dermatology, orthopedics, pediatrics, cardiology, gynecology, therapy and other areas of modern medicine. Both non-branded medicinal products and FITOPHARM brands held leading positions in their respective categories. Consumers know such names as "Eroton", "Extraterm", "Sedafyton", "Capsiol", etc.
www.promoboz.com
www.promoboz.com |
www.cphem.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
